REFERENCES

• KesslerRC.BerglundP.DernierO.JinR.MerikangasKR.WaltersEE.Lifetime prevalence and age-of-onset distributions of DSM-IV disorders in the National Comorbidity Survey Replication.Arch Gen Psychiatry.200562659360215939837
   PubMed Web of Science ®Google Scholar
• BruceSE.YonkersKA.OttoMW.et alInfluence of psychiatric comorbidity on recovery and recurrence in generalized anxiety disorder, social phobia, and panic disorder: a 12-year prospective study.Am J Psychiatry.200516261179118715930067
   PubMed Web of Science ®Google Scholar
• EtkinA.Neurobiology of anxiety: from neural circuits to novel solutions?Depress Anxiety.201229535535822553005
   PubMed Web of Science ®Google Scholar
• RavindranLN.SteinMB.The pharmacologic treatment of anxiety disorders: a review of progress.J Clin Psychiatry.201071783985420667290
   PubMed Web of Science ®Google Scholar
• PecknoldJC.SwinsonRP.KuchK.LewisCP.Alprazolam in panic disorder and agoraphobia: Results from a multicenter trial: III. Discontinuation effects.Arch Gen Psychiatry.1988454294363282479
   PubMed Web of Science ®Google Scholar
• KleinE.ColinV.StolkJ.LenoxRH.Alprazolam withdrawal in patients with panic disorder and generalized anxiety disorder: vulnerability and effect of carbamazepine.Am J Psychiatry.1994151176017667977882
   PubMed Web of Science ®Google Scholar
• GoddardAW.BrouetteT.AlmaiA.JettyP.WoodsSW.CharneyD.Early coadministration of clonazepam with sertraline for panic disorder.Arch Gen Psychiatry.200158768168611448376
   PubMed Web of Science ®Google Scholar
• OlatunjiBO.CislerJM.DeaconBJ.Efficacy of cognitive behavioral therapy for anxiety disorders: a review of meta-analytic findings.Psychiatr Clin North Am.201033355757720599133
   PubMed Web of Science ®Google Scholar
• WilamowskaZA.Thompson-HollandsJ.FairholmeCP.EllardKK.FarchioneTJ.BarlowDH.Conceptual background, development, and preliminary data from the unified protocol for transdiagnostic treatment of emotional disorders.Depress Anxiety.2010271088289020886609
   PubMed Web of Science ®Google Scholar
• MitteK.Meta-analysis of cognitive-behavioral treatments for generalized anxiety disorder: a comparison with pharmacotherapy.Psychol Bull.2005131578579516187860
   PubMed Web of Science ®Google Scholar
• DavidsonJR.FoaEB.HuppertJD.et alFluoxetine, comprehensive cognitive behavioral therapy, and placebo in generalized social phobia.Arch Gen Psychiatry.200461101005101315466674
   PubMed Web of Science ®Google Scholar
• MitteK.A meta-analysis of the efficacy of psycho- and pharmaco-therapy in panic disorder with and without agoraphobia.J Affect Disord.2005881274516005982
   PubMed Web of Science ®Google Scholar
• FoaEB.LiebowitzMR.KozakMJ.et alRandomized, placebo-controlled trial of exposure and ritual prevention, clomipramine, and their combination in the treatment of obsessive-compulsive disorder.Am J Psychiatry.2005162115116115625214
   PubMed Web of Science ®Google Scholar
• DuanN.BraslowJT.WeiszJR.WellsKB.Fidelity, adherence, and robustness of interventions.Psychiatr Serv.200152441311274482
   PubMed Web of Science ®Google Scholar
• OttoMW.SmitsJA.ReeseHE.Cognitive-behavioral therapy for the treatment of anxiety disorders.J Clin Psychiatry.200465suppl 5344115078117
   PubMedGoogle Scholar
• SteinMB.Roy-ByrnePP.CraskeMG.et alQuality of and patient satisfaction with primary health care for anxiety disorders.J Clin Psychiatry.201172797097621367351
   PubMed Web of Science ®Google Scholar
• KeitnerGl.MansfieldAK.Management of treatment-resistant depression.Psychiatr Clin North Am.201235124926522370501
   PubMed Web of Science ®Google Scholar
• GoismanRM.WarshawMG.KellerMB.Psychosocial treatment prescriptions for generalized anxiety disorder, panic disorder, and social phobia, 1991-1996.Am J Psychiatry.1999156111819182110553751
   PubMed Web of Science ®Google Scholar
• YonkersKA.EllisonJM.SheraDM.et alDescription of antipanic therapy in a prospective longitudinal study.J Clin Psychopharmacol.19961632232328784654
   PubMed Web of Science ®Google Scholar
• YoungAS.KlapR.SherbourneCD.WellsKB.The quality of care for depressive and anxiety disorders in the United States.Arch Gen Psychiatry.2001581556111146758
   PubMed Web of Science ®Google Scholar
• LondborgPD.HegelMT.GoldsteinS.et alSertraline treatment of posttraumatic stress disorder: results of 24 weeks of open-label continuation treatment.J Clin Psychiatry.200162532533111411812
   PubMed Web of Science ®Google Scholar
• MontgomerySA.SheehanDV.MeoniP.HaudiquetV.HackettD.Characterization of the longitudinal course of improvement in generalized anxiety disorder during long-term treatment with venlafaxine XR.J Psychiatr Res.200236420921712191625
   PubMed Web of Science ®Google Scholar
• ZitrinCM.KleinDF.WoernerMG.RossDC.Treatment of phobias. I. Comparison of imipramine hydrochloride and placebo.Arch Gen Psychiatry.19834021251386337578
   PubMed Web of Science ®Google Scholar
• LoebelAD.HydeTS.DunnerDL.Early placebo response in anxious and depressed patients.J Clin Psychiatry.19864752302333516977
   PubMed Web of Science ®Google Scholar
• MarcusSM.GormanJ.ShearMK.et alA comparison of medication side effect reports by panic disorder patients with and without concomitant cognitive behavior therapy.Am J Psychiatry.2007164227327517267790
   PubMed Web of Science ®Google Scholar
• OttoMW.PollackMH.SachsGS.ReiterSR.Meltzer-BrodyS.RosenbaurnJF.Discontinuation of benzodiazepine treatment: efficacy of cognitive-behavioral therapy for patients with panic disorder.Am J Psychiatry.199315010148514908379551
   PubMed Web of Science ®Google Scholar
• IwanamiT.MaeshimaH.BabaH.et alPsychomotor agitation in major depressive disorder is a predictive factor of mood-switching.J Affect Disord.201517018518925248024
   PubMed Web of Science ®Google Scholar
• PevelerR.GeorgeC.KinmonthAL.CampbellM.ThompsonC.Effect of antidepressant drug counselling and information leaflets on adherence to drug treatment in primary care: randomised controlled trial.BMJ.1999319721061261510473477
   PubMedGoogle Scholar
• MojtabaiR.OlfsonM.MechanicD.Perceived need and help-seeking in adults with mood, anxiety, or substance use disorders.Arch Gen Psychiatry.2002591778411779286
   PubMed Web of Science ®Google Scholar
• GriloCM.MoneyR.BarlowDH.et alPretreatment patient factors predicting attrition from a multicenter randomized controlled treatment study for panic disorder.Compr Psychiatry.19983963233329829138
   PubMed Web of Science ®Google Scholar
• HofmannSG.BarlowDH.PappLA.et alPretreatment attrition in a comparative treatment outcome study on panic disorder.Am J Psychiatry.2998155143479433337
   PubMed Web of Science ®Google Scholar
• ZoellnerLA.FeenyNC.CochranB.PruittL.Treatment choice for PTSD.Behav Res Then.2003418879886
   PubMed Web of Science ®Google Scholar
• KwanBM.DimidjianS.RizviSL.Treatment preference, engagement, and clinical improvement in pharmacotherapy versus psychotherapy for depression.Behav Res Ther.201048879980420462569
   PubMed Web of Science ®Google Scholar
• WeissmanMM.VerdeliH.GameroffMJ.et alNational survey of psychotherapy training in psychiatry, psychology, and social work.Arch Gen Psychiatry.200663892593416894069
   PubMed Web of Science ®Google Scholar
• GlennD.GolinelliD.RoseRD.et alWho gets the most out of cognitive behavioral therapy for anxiety disorders? The role of treatment dose and patient engagement.J Consult Clin Psychol.201381463964923750465
   PubMed Web of Science ®Google Scholar
• VilarimMM.Rocha AraujoDM.NardiAE.Caffeine challenge test and panic disorder: a systematic literature review.Exp Rev Neurotherapeutics.201111811851195
   PubMed Web of Science ®Google Scholar
• DewsPB.O'BrienCP.BergmanJ.Caffeine: behavioral effects of withdrawal and related issues.Food Chem Toxicol.20024091257126112204389
   PubMed Web of Science ®Google Scholar
• Roy-ByrnePP.UhdeTW.PostRM.Effects of one night's sleep deprivation on mood and behavior in panic disorder. Patients with panic disorder compared with depressed patients and normal controls.Arch Gen Psychiatry.19864398958993753167
   PubMed Web of Science ®Google Scholar
• Roy-ByrnePP.RussoJ.CowleyDS.KatonWJ.Panic disorder in public sector primary care: clinical characteristics and illness severity compared with “mainstream” primary care panic disorder.Depress Anxiety.2003172515712621592
   PubMed Web of Science ®Google Scholar
• YonkersKA.DyckIR.WarshawM.KellerMB.Factors predicting the clinical course of generalised anxiety disorder.Br J Psychiatry.200017654454910974960
   PubMed Web of Science ®Google Scholar
• WadeSL.MonroeSM.MichelsonLK.Chronic life stress and treatment outcome in agoraphobia with panic attacks.Am J Psychiatry.199315010149114958379552
   PubMed Web of Science ®Google Scholar
• CrippaJA.ZuardiAW.Martin-SantosR.et alCannabis and anxiety: a critical review of the evidence.Hum Psychopharmacol.200924751552319693792
   PubMed Web of Science ®Google Scholar
• NeumeisterA.The endocannabinoid system provides an avenue for evidence-based treatment development for PTSD.Depress Anxiety.2013302939623225490
   PubMed Web of Science ®Google Scholar
• Campbell-SillsL.SteinMB.SherbourneCD.et alEffects of medical comorbidity on anxiety treatment outcomes in primary care.Psychosomat Med.2013758713720
   PubMed Web of Science ®Google Scholar
• CoryellW.FiedorowiczJG.SolomonD.LeonAC.RiceJP.KellerMB.Effects of anxiety on the long-term course of depressive disorders.Br J Psychiatry.2012200321021521984801
   PubMed Web of Science ®Google Scholar
• FrankE.CassanoGB.RucciP.et alPredictors and moderators of time to remission of major depression with interpersonal psychotherapy and SSRI pharmacotherapy.Psychol Med.201141115116220380782
   PubMed Web of Science ®Google Scholar
• lonescuDF.LuckenbaughDA.NiciuMJ.et alEffect of baseline anxious depression on initial and sustained antidepressant response to ketamine.J Clin Psychiatry.2014759e93293825295436
   PubMed Web of Science ®Google Scholar
• KoukopoulosA.SaniG.GhaemiSN.Mixed features of depression: why DSM-5 is wrong (and so was DSM-IV).Br J Psychiatry.201320313523818531
   PubMed Web of Science ®Google Scholar
• SalaR.GoldsteinBl.MorcilloC.LiuSM.CastellanosM.BlancoC.Course of comorbid anxiety disorders among adults with bipolar disorder in the U.S. population.J Psychiatr Res.201246786587222534180
   PubMed Web of Science ®Google Scholar
• GoldsteinBl.LevittAJ.The specific burden of comorbid anxiety disorders and of substance use disorders in bipolar I disorder.Bipolar Disord.2008101677818199243
   PubMed Web of Science ®Google Scholar
• GilmanSE.DupuyJM.PerilsRH.Risks for the transition from major depressive disorder to bipolar disorder in the National Epidemiologic Survey on Alcohol and Related Conditions.J Clin Psychiatry.201273682983622394428
   PubMed Web of Science ®Google Scholar
• GaoK.KempDE.ConroyC.GanocySJ.FindlingRL.CalabreseJR.Comorbid anxiety and substance use disorders associated with a lower use of mood stabilisers in patients with rapid cycling bipolar disorder: a descriptive analysis of the cross-sectional data of 566 patients.Int J Clin Pract.201064333634420456174
   PubMed Web of Science ®Google Scholar
• StrawnJR.AdlerCM.McNamaraRK.et alAntidepressant tolerability in anxious and depressed youth at high risk for bipolar disorder: a prospective naturalistic treatment study.Bipolar Disord.201416552353023937313
   PubMed Web of Science ®Google Scholar
• PostRM.AltshulerLL.LeverichGS.et alMood switch in bipolar depression: comparison of adjunctive venlafaxine, bupropion and sertraline.Br J Psychiatry.200618912413116880481
   PubMed Web of Science ®Google Scholar
• PacchiarottiI.BondDJ.BaldessariniRJ.et alThe International Society for Bipolar Disorders (ISBD) task force report on antidepressant use in bipolar disorders.Ami J Psychiatry.20131701112491262
   PubMed Web of Science ®Google Scholar
• SwannAC.LaferB.PerugiG.et alBipolar mixed states: an international society for bipolar disorders task force report of symptom structure, course of illness, and diagnosis.Ami J Psychiatry.201317013142
   PubMed Web of Science ®Google Scholar
• PhelpsJ.GhaemiSN.The mistaken claim of bipolar'overdiagnosis': solving the false positives problem for DSM-5/ICD-11.Acta Psychiatr Scand.2012126639540122900986
   PubMed Web of Science ®Google Scholar
• DawsonDA.GrantBF.StinsonFS.ZhouY.Effectiveness of the derived Alcohol Use Disorders Identification Test (AUDIT-C) in screening for alcohol use disorders and risk drinking in the US general population.Alcohol Clin Exp Res.200529584485415897730
   PubMed Web of Science ®Google Scholar
• ForbesD.CreamerM.HawthorneG.AllenN.McHughT.Comorbidity as a predictor of symptom change after treatment in combat-related posttraumatic stress disorder.J Nerv Ment Dis.20031912939912586962
   PubMed Web of Science ®Google Scholar
• Roy-ByrneP.ScheeleL.BrinkleyJ.et alAdult attention-deficit hyperactivity disorder: assessment guidelines based on clinical presentation to a specialty clinic.Compr Psychiatry.19973831331409154368
   PubMed Web of Science ®Google Scholar
• Moderators and mediators of treatment response for children with attention-deficit/hyperactivity disorder: the Multimodal Treatment Study of children with Attention-deficit/hyperactivity disorder.Arch Gen Psychiatry.199956121088109610591284
   PubMed Web of Science ®Google Scholar
• FurukawaTA.WatanabeN.ChurchillR.Psychotherapy plus antidepressant for panic disorder with or without agoraphobia: systematic review.Br J Psychiatry.200618830531216582055
   PubMed Web of Science ®Google Scholar
• BlancoC.HeimbergRG.SchneierFR.et alA placebo-controlled trial of phenelzine, cognitive behavioral group therapy, and their combination for social anxiety disorder.Arch Gen Psychiatry.201067328629520194829
   PubMed Web of Science ®Google Scholar
• WetherellJL.PetkusAJ.WhiteKS.et alAntidepressant medication augmented with cognitive-behavioral therapy for generalized anxiety disorder in older adults.Am J Psychiatry.2013170778278923680817
   PubMed Web of Science ®Google Scholar
• MarksIM.SwinsonRP.BasogluM.et alAlprazolam and exposure alone and combined in panic disorder with agoraphobia. A controlled study in London and Toronto.Br J Psychiatry.19931627767878101126
   PubMed Web of Science ®Google Scholar
• WestraHA.StewartSH.ConradBE.Naturalistic manner of benzodiazepine use and cognitive behavioral therapy outcome in panic disorder with agoraphobia.J Anxiety Disord.200216323324612214810
   PubMed Web of Science ®Google Scholar
• PowerKG.SimpsonRJ.SwansonV.WallaceLA.Controlled comparison of pharmacological and psychological treatment of generalized anxiety disorder in primary care.Br J Gen Pract.1990403362892942081065
   PubMed Web of Science ®Google Scholar
• WatanabeN.ChurchillR.FurukawaTA.Combined psychotherapy plus benzodiazepines for panic disorder.Cochrane Database Syst Rev.2009 1CD00533519160253
   PubMed Web of Science ®Google Scholar
• KampmanM.KeijsersGP.HoogduinCA.HendriksGJ.A randomized, double-blind, placebo-controlled study of the effects of adjunctive paroxetine in panic disorder patients unsuccessfully treated with cognitivebehavioral therapy alone.J Clin Psychiatry.200263977277712363116
   PubMed Web of Science ®Google Scholar
• SimonNM.OttoMW.WorthingtonJJ.et alNext-step strategies for panic disorder refractory to initial pharmacotherapy: a 3-phase randomized clinical trial.J Clin Psychiatry.200970111563157019814948
   PubMed Web of Science ®Google Scholar
• Roy-ByrneP.CraskeMG.SullivanG.et alDelivery of evidence-based treatment for multiple anxiety disorders in primary care: a randomized controlled trial.JAMA.19 2010303191921192820483968
   PubMed Web of Science ®Google Scholar
• HintonDE.ChheanD.PichV.SafrenSA.HofmannSG.PollackMH.A randomized controlled trial of cognitive-behavior therapy for Cambodian refugees with treatment-resistant PTSD and panic attacks: a cross-over design.J Trauma Stress.200518661762916382423
   PubMed Web of Science ®Google Scholar
• SimpsonHB.FoaEB.LiebowitzMR.et alCognitive-behavioral therapy vs risperidone for augmenting serotonin reuptake inhibitors in obsessive-compulsive disorder: a randomized clinical trial.JAMA Psychiatry.201370111190119924026523
   PubMed Web of Science ®Google Scholar
• SulkowskiML.GellerDA.LewinAB.et alThe future of D-cycloserine and other cognitive modifiers in obsessive-compulsive and related disorders.Curr Psychiatry Rev.201410431732425383074
   PubMedGoogle Scholar
• HofmannSG.SmitsJA.RosenfieldD.et alD-Cycloserine as an augmentation strategy with cognitive-behavioral therapy for social anxiety disorder.Am J Psychiatry.2013170775175823599046
   PubMed Web of Science ®Google Scholar
• de KleineRA.HendriksGJ.KustersWJ.BroekmanTG.van MinnenA.A randomized placebo-controlled trial of D-cycloserine to enhance exposure therapy for posttraumatic stress disorder.Biol Psychiatry.2012711196296822480663
   PubMed Web of Science ®Google Scholar
• SmitsJA.RosenfieldD.OttoMW.et alD-cycloserine enhancement of fear extinction is specific to successful exposure sessions: evidence from the treatment of height phobia.Biol Psychiatry.201373111054105823332511
   PubMed Web of Science ®Google Scholar
• PandeAC.DavidsonJR.JeffersonJW.et alTreatment of social phobia with gabapentin: a placebo-controlled study.J Clin Psychopharmacol.199919434134810440462
   PubMed Web of Science ®Google Scholar
• PandeAC.PollackMH.CrockattJ.et alPlacebo-controlled study of gabapentin treatment of panic disorder.J Clin Psychopharmacol.200020446747110917408
   PubMed Web of Science ®Google Scholar
• LydiardRB.RickelsK.HermanB.FeltnerDE.Comparative efficacy of pregabalin and benzodiazepines in treating the psychic and somatic symptoms of generalized anxiety disorder.Int J Neuropsychopharmacol.201013222924119737439
   PubMed Web of Science ®Google Scholar
• FeltnerDE.CrockattJG.DubovskySJ.et alA randomized, doubleblind, placebo-controlled, fixed-dose, multicenter study of pregabalin in patients with generalized anxiety disorder.J Clin Psychopharmacol.200323324024912826986
   PubMed Web of Science ®Google Scholar
• KasperS.HermanB.NivoliG.et alEfficacy of pregabalin and venlafaxine-XR in generalized anxiety disorder: results of a double-blind, placebo-controlled 8-week trial.Int Clin Psychopharmacol.2009242879621456104
   PubMed Web of Science ®Google Scholar
• RaskindMA.PetersonK.WilliamsT.et alA trial of prazosin for combat trauma PTSD with nightmares in active-duty soldiers returned from Iraq and Afghanistan.Am J Psychiatry.201317091003101023846759
   PubMed Web of Science ®Google Scholar
• RaskindMA.PeskindER.KanterED.et alReduction of nightmares and other PTSD symptoms in combat veterans by prazosin: a placebo-controlled study.Am J Psychiatry.2003160237137312562588
   PubMed Web of Science ®Google Scholar
• EisenbergDM.DavisRB.EttnerSL.et alTrends in alternative medicine use in the United States, 1990-1997: results of a follow-up national survey.JAMA.199828018156915759820257
   PubMed Web of Science ®Google Scholar
• Roy-ByrnePP.BystritskyA.RussoJ.CraskeMG.SherbourneCD.SteinMB.Use of herbal medicine in primary care patients with mood and anxiety disorders.Psychosomatics.200546211712215774949
   PubMed Web of Science ®Google Scholar
• SarrisJ.MclntyreE.CamfieldDA.Plant-based medicines for anxiety disorders, part 2: a review of clinical studies with supporting preclinical evidence.CNS Drugs.201327430131923653088
   PubMed Web of Science ®Google Scholar
• SarrisJ.PanossianA.SchweitzerI.StoughC.ScholeyA.Herbal medicine for depression, anxiety and insomnia: a review of psychopharmacology and clinical evidence.Eur Neuropsychopharmacol.2011211284186021601431
   PubMed Web of Science ®Google Scholar
• MilrodB.LeonAC.BuschF.et alA randomized controlled clinical trial of psychoanalytic psychotherapy for panic disorder.Am J Psychiatry.2007164226527217267789
   PubMed Web of Science ®Google Scholar
• LeichsenringF.SalzerS.JaegerU.et alShort-term psychodynamic psychotherapy and cognitive-behavioral therapy in generalized anxiety disorder: a randomized, controlled trial.Am J Psychiatry.2009166887588119570931
   PubMed Web of Science ®Google Scholar
• LeichsenringF.SalzerS.BeutelME.et alPsychodynamic therapy and cognitive-behavioral therapy in social anxiety disorder: a multicenter randomized controlled trial.Am J Psychiatry.2013170775976723680854
   PubMed Web of Science ®Google Scholar
• MarkowitzJC.LipsitzJ.MilrodBL.Critical review of outcome research on interpersonal psychotherapy for anxiety disorders.Depress Anxiety.201431431632524493661
   PubMed Web of Science ®Google Scholar
• MarkowitzJC.PetkovaE.NeriaY.et alIs exposure necessary? A randomized clinical trial of interpersonal psychotherapy for PTSD.Am J Psychiatry.2015172543044025677355
   PubMed Web of Science ®Google Scholar
• SegalZV.BielingP.YoungT.et alAntidepressant monotherapy vs sequential pharmacotherapy and mindfulness-based cognitive therapy, or placebo, for relapse prophylaxis in recurrent depression.Arch Gen Psychiatry.201067121256126421135325
   PubMed Web of Science ®Google Scholar
• ArchJJ.AyersCR.BakerA.AlmklovE.DeanDJ.CraskeMG.Randomized clinical trial of adapted mindfulness-based stress reduction versus group cognitive behavioral therapy for heterogeneous anxiety disorders.Behav Res Ther.2013514-518519623419887
   PubMed Web of Science ®Google Scholar
• BroocksA.BandelowB.PekrunG.et alComparison of aerobic exercise, clomipramine, and placebo in the treatment of panic disorder.Am J Psychiatry.199815556036099585709
   PubMed Web of Science ®Google Scholar
• BartleyCA.HayM.BlochMH.Meta-analysis: aerobic exercise for the treatment of anxiety disorders.Prog Neuropsychopharmacol Biol Psychiatry.201345343923643675
   PubMed Web of Science ®Google Scholar
• JayakodyK.GunadasaS.HoskerC.Exercise for anxiety disorders: systematic review.Br J Sports Med.201448318719623299048
   PubMed Web of Science ®Google Scholar
• PollackMH.Van AmeringenM.SimonNM.et alA double-blind randomized controlled trial of augmentation and switch strategies for refractory social anxiety disorder.Am J Psychiatry.20141711445324399428
   PubMed Web of Science ®Google Scholar
• van BalkornAJ.de BeursE.KoeleP.LangeA.van DyckR.Long-term benzodiazepine use is associated with smaller treatment gain in panic disorder with agoraphobia.J Nerv Ment Dis.199618421331358596113
   PubMed Web of Science ®Google Scholar
• FavaGA.GrandiS.BelluardoP.et alBenzodiazepines and anxiety sensitivity in panic disorder.Prog Neuropsychopharmacol Biol Psychiatry.1994187116311687846286
   PubMed Web of Science ®Google Scholar
• MellmanTA.ByersPM.AugensteinJS.Pilot evaluation of hypnotic medication during acute traumatic stress response.J Trauma Stress.19981135635699690193
   PubMed Web of Science ®Google Scholar
• RisseSC.WhittersA.BurkeJ.ChenS.ScurfieldRM.RaskindMA.Severe withdrawal symptoms after discontinuation of alprazolam in eight patients with combat-induced posttraumatic stress disorder.J Clin Psychiatry.19905152062092335496
   PubMed Web of Science ®Google Scholar
• RickelsK.DowningR.SchweizerE.HassmanH.Antidepressants for the treatment of generalized anxiety disorder. A placebo-controlled comparison of imipramine, trazodone, and diazepam.Arch Gen Psychiatry.199350118848958215814
   PubMed Web of Science ®Google Scholar
• PollackM.KinrysG.KrystalA.et alEszopiclone coadministered with escitalopram in patients with insomnia and comorbid generalized anxiety disorder.Arch Gen Psychiatry.200865555156218458207
   PubMed Web of Science ®Google Scholar
• PollackMH.HogeEA.WorthingtonJJ.et alEszopiclone for the treatment of posttraumatic stress disorder and associated insomnia: a randomized, double-blind, placebo-controlled trial.J Clin Psychiatry.201172789289721367352
   PubMed Web of Science ®Google Scholar
• DeppingAM.KomossaK.KisslingW.LeuchtS.Second-generation antipsychotics for anxiety disorders.Cochrane Database Syst Rev.2010 12CD00812021154392
   PubMed Web of Science ®Google Scholar
• DoldM.AignerM.LanzenbergerR.KasperS.Antipsychotic augmentation of serotonin reuptake inhibitors in treatment-resistant obsessivecompulsive disorder: a meta-analysis of double-blind, randomized, placebo-controlled trials.Int J Neuropsychopharmacol.201316355757422932229
   PubMed Web of Science ®Google Scholar
• LaLondeCD.Van LieshoutRJ.Treating generalized anxiety disorder with second generation antipsychotics: a systematic review and metaanalysis.J Clin Psychopharmacol.201131332633321508847
   PubMed Web of Science ®Google Scholar
• WangHR.WooYS.BahkWM.Atypical antipsychotics in the treatment of posttraumatic stress disorder.Clin Neuropharmacol.201336621622224201234
   PubMed Web of Science ®Google Scholar
• KrystalJH.RosenheckRA.CramerJA.et alAdjunctive risperidone treatment for antidepressant-resistant symptoms of chronic military service-related PTSD: a randomized trial.JAMA.2011306549350221813427
   PubMed Web of Science ®Google Scholar
• CareyP.SulimanS.GanesanK.SeedatS.SteinDJ.Olanzapine monotherapy in posttraumatic stress disorder: efficacy in a randomized, double-blind, placebo-controlled study.Hum Psychopharmacol.201227438639122730105
   PubMed Web of Science ®Google Scholar
• HirschmannS.DannonPN.lancuI.DolbergOT.ZoharJ.GrunhausL.Pindolol augmentation in patients with treatment-resistant panic disorder: A double-blind, placebo-controlled trial.J Clin Psychopharmacol.200020555655911001241
   PubMed Web of Science ®Google Scholar
• SteinMB.SareenJ.HamiS.ChaoJ.Pindolol potentiation of paroxetine for generalized social phobia: a double-blind, placebo-controlled, crossover study.Am J Psychiatry.2001158101725172711579011
   PubMed Web of Science ®Google Scholar
• SteinMB.LiebowitzMR.LydiardRB.PittsCD.BushnellW.GergelI.Paroxetine treatment of generalized social phobia (social anxiety disorder): a randomized controlled trial.JAMA.199828087087139728642
   PubMed Web of Science ®Google Scholar